Skip to main content

Table 1 Patient demographics

From: Post-operative atrial fibrillation examined using whole-genome RNA sequencing in human left atrial tissue

 

All (n = 62)

No poAF (n = 41)

poAF (n = 21)

p-value

Female gender

27 (44%)

17 (41%)

10 (47%)

0.85

Age (mean)

58.7

56.0

64.8

0.006

Past Medical History

Smoking (Any)

21 (32%)

12 (29%)

8 (38%)

0.68

Myocardial Infarction

2 (3%)

1 (2%)

1 (5%)

1.00

Hypertension

34 (55%)

18 (44%)

17 (81%)

0.01

Diabetes

7 (11%)

4 (11%)

3 (15%)

0.94

Atrial fibrillation

12 (19%)

7 (17%)

5 (24%)

0.76

Mitral Stenosis (severe)

5 (8%)

3 (8%)

2 (11%)

0.65

Mitral Insufficiency

None

1 (2%)

0 (0%)

1 (5%)

 

Mild

1 (2%)

1 (2%)

0 (0%)

 

Moderate

5 (8%)

4 (10%)

1 (5%)

 

Severe

55 (89%)

36 (88%)

19 (90%)

0.48

Preoperative medications

ACE inhibitor /ARB

27 (44%)

16 (39%)

12 (57%)

0.28

β-blockers

29 (47%)

18 (44%)

10 (48%)

0.99

Calcium channel inhibitors

8 (13%)

7 (17%)

1 (5%)

0.38

HMG-CoA reductase inhibitor

19 (31%)

9 (21%)

10 (50%)

0.05

Perioperative information

Left ventricular ejection fraction

0.60

0.61

0.59

0.39

Left atrium volume (ml/m2)

71

70

73

0.75

Cross-clamp time (min)

106

108

101

0.58

Cardiopulmonary bypass time (min)

144

146

143

0.85

  1. Patient characteristic of individuals included in the study. poAF – post-operative atrial fibrillation. ACE – angiotension-converting enzyme ARB – aldosterone II receptor blocker HGM-CoA -hydroxy-3-methylglutaryl-coenzyme